Vapogenix
Jump to navigation
Jump to search
"Vapogenix Inc. was founded in 2006 by Dr. Allen Burton, Dr. Phillip Phan and Ms. Danguole Altman to develop novel formulations of currently used medications for better treatment of pain. The company began operations in November 2007 after licensing intellectual property rights to its core technology. "[1]
Board
Accessed April 2013: [2]
Management and Key Personnel
- Allen Burton, M.D. – Scientific Founder and Co-Chair of the Scientific Advisory Board
- Phillip Phan, M.D. – Scientific Founder and Co-Chair of the Scientific Advisory Board
- Danguole Altman – President, CEO, and Director
- Heather Giles, Ph.D. – Chief Scientific Officer
- Terry B. Farmer, Ph.D. – Director of CMC and Analytical Services
Board of Directors
- Danguole Altman – President, CEO and Director
- George Davitt – President of Aragain Capital Management, Inc. and Director of the McCall MacBain Foundation
- Chris Jorgenson – Managing Director of Pamoja Capital
Scientific Advisory Board
- Allen Burton, M.D. – Scientific Founder and Co-Chair of the Scientific Advisory Board
- Phillip Phan, M.D. – Scientific Founder and Co-Chair of the Scientific Advisory Board
- Patrick Dougherty, Ph.D. – Professor in the Department of Pain Medicine at M.D. Anderson Cancer Center
- Duncan Haynes, Ph.D. – Professor Emeritus of the University of Miami School of Medicine and President of Pharma-Logic Discovery.
- Peter Lacouture, Ph.D. – Executive Director of Scientific and Medical Affairs at Magidom Discovery
Business Advisory Board
- David Anderson – Chairman of the Board, Plx Pharma, Inc. and Nanospectra Biosciences, Inc.
- Bette Schultz – President of Business & Licensing Strategies, LLC
- William Altman – President and CEO of CoreInnova, Inc.
Contact
Resources and articles
Related Sourcewatch
References
- ↑ Vapogenix About, organizational web page, accessed April 8, 2013.
- ↑ Vapogenix Leadership, organizational web page, accessed April 8, 2013.